Revere, MA, United States of America

Ervin Sinani

This inventor holds 1 USPTO granted patent. Top assignee: Eyetech Inc.. Active years: 2010.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ervin Sinani

Introduction

Ervin Sinani is a notable inventor based in Revere, MA (US). He has made significant contributions to the field of biotechnology, particularly in the detection of modified nucleic acid oligonucleotides. His work has implications for diagnostics and therapeutics, showcasing the importance of innovation in medical science.

Latest Patents

Ervin Sinani holds a patent for the invention titled "Detection of oligonucleotides by dual hybridization." This invention provides methods and compositions for detecting and quantifying modified nucleic acid oligonucleotides. These methods are particularly useful for identifying diagnostic and therapeutic synthetic modified oligonucleotides, such as aptamers, RNAi, siRNA, antisense oligonucleotides, or ribozymes in biological samples. He has 1 patent to his name.

Career Highlights

Sinani is currently associated with Eyetech Inc., where he continues to advance his research and development efforts. His work at Eyetech Inc. reflects his commitment to innovation in the biotechnology sector.

Collaborations

Some of his notable coworkers include Pericles Calias and Gregory S Robinson. Their collaboration contributes to the innovative environment at Eyetech Inc., fostering advancements in biotechnology.

Conclusion

Ervin Sinani's contributions to the field of biotechnology through his patent and work at Eyetech Inc. highlight the vital role of inventors in advancing medical science. His innovative methods for detecting modified nucleic acid oligonucleotides pave the way for future developments in diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…